Delivery Order SPE2DB22D3010-SPE2DB24FP1QR
Award Date
2/7/24
Potential Completion Date
2/8/24
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,191.08 firm fixed-price delivery order is for the supply of 4563033480 - Valganciclovir HCL 50 MG/ML 88ML, with a period of performance ending on December 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Valganciclovir 450 mg tablets. The $1,044.98 firm-fixed-price contract has a performance period through May 2, 2022. This contract is not designated as a set-aside award. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a wide...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,349.44 firm fixed-price contract is for the delivery of 4559897831 - Valganciclovir 450 mg tablets. The award is not set aside for any particular business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,158,577 units of Valganciclovir 450 mg tablets in 60-count packages, with a ceiling value of $3,526.68. It is a firm fixed-price delivery order contract with a performance period ending on May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $8,191.37, is for the delivery of valganciclovir hydrochloride, a pharmaceutical product used in the treatment of certain medical conditions. The contract has a period of performance through May 7, 2024, and is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,530.43, is for the delivery of 60 tablets of valganciclovir 450 mg. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has a completion date of March 12, 2025 and was awarded on March 11, 2025. This award is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60-count bottles of the drug Valganciclovir 450 mg tablets, with a ceiling value of $3,193.93 and a period of performance through April 14, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,147.05 firm fixed-price delivery order is for the supply of 60 tablets of 450 mg Valganciclovir, a medication used to treat cytomegalovirus infections. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,668.46 and is for the delivery of valganciclovir 450 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 15, 2023. This award is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award, valued at $3,507.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 units of 450 mg Valganciclovir tablets, a medication used for the treatment of cytomegalovirus (CMV) infections. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 31, 2024. AmerisourceBergen holds a...